Insitro
Machine learning platform that integrates biological data to identify and optimize drug candidates
- Sector
- Biotech
- Headquarters
- South San Francisco, CA
- Founded
- 2018
- Latest Form D
- $143M, May 2020
- Total capital
- $143M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $143M
- 1 Form D · last May 2020
- 77 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 22
- 18 pending · first 2024
- Rank in peer group#2 of 55
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$143M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 55 peers
Line = medianBiotech · Software
- Granted patents#2 · top 4%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Daphne KollerResearcherExecutive Officer, DirectorLinked by 1 patent
- Duane ValzExecutive OfficerNamed in SEC Form D filings
- Mary RozenmanExecutive OfficerNamed in SEC Form D filings
- Robert NelsenDirectorNamed in SEC Form D filings
- Vijay PandeDirectorNamed in SEC Form D filings
What it has protected
USPTO · 22 granted of 40- New patentMachine-learning-enabled Imputation Of Spatial Omics Data Based On Histopathology Image DataUSPTOUS 12,755,567
- GrantedIn Situ Sequencing Of Rna Transcripts With Non-uniform 5' EndsUSPTOUS 12,668,841
- GrantedSynthon Embeddings For Modeling Dna-encoded LibrariesUSPTOUS 12,665,048
Show all 40 patent records
- Machine-learning-enabled Imputation Of Spatial Omics Data Based On Histopathology Image DataOct 6, 2026 · US 12,755,567Granted
- In Situ Sequencing Of Rna Transcripts With Non-uniform 5' EndsJun 30, 2026 · US 12,668,841Granted
- Synthon Embeddings For Modeling Dna-encoded LibrariesJun 23, 2026 · US 12,665,048Granted
- Oligonucleotide Directed And Recorded Combinitorial Synthesis Of Encoded Probe MoleculesJun 16, 2026 · US 12,655,420Granted
- Microscopy Image Analyses For Disease ModelingMar 12, 2026 · Application 19392854Pending
- Cellular Time-series Imaging, Modeling, And Analysis SystemMar 12, 2026 · Application 19391805Pending
- Compositions And Methods For Treating Nonalcoholic Fatty Liver DiseaseFeb 26, 2026 · Application 19305728Pending
- Cellular Time-series Imaging, Modeling, And Analysis SystemFeb 5, 2026 · Application 19357697Pending
- Biological Image Transformation Using Machine-learning ModelsFeb 3, 2026 · US 12,541,983Granted
- Machine-learning-enabled Imputation Of Spatial Omics Data Based On Histopathology Image DataJan 22, 2026 · Application 19341997Pending
- Biological Image Transformation Using Machine-learning ModelsDec 30, 2025 · US 12,511,918Granted
- Microscopy Image Analyses For Disease ModelingDec 23, 2025 · US 12,505,549Granted
- Biological Image Transformation Using Machine-learning ModelsNov 25, 2025 · US 12,482,280Granted
- Autonomous Cell Imaging And Modeling SystemNov 4, 2025 · US 12,462,386Granted
- Compositions And Methods For Treating Metabolic Dysfunction-associated Steatotic Liver DiseaseOct 30, 2025 · Application 19189062Pending
- Methods Of Preparing Bivalent MoleculesOct 30, 2025 · Application 18570419Pending
- Machine-learning-enabled Imputation Of Spatial Omics Data Based On Histopathology Image DataOct 21, 2025 · US 12,450,926Granted
- Methods Of Preparing Oligonucleotide-directed Combinatorial LibrariesOct 16, 2025 · Application 19175408Pending
- Machine-learning-enabled Predictive Biomarker Discovery And Patient Stratification Using Standard-of-care DataAug 28, 2025 · Application 19205753Pending
- Discovery PlatformAug 14, 2025 · Application 19054563Pending
- Machine-learning-enabled Predictive Biomarker Discovery And Patient Stratification Using Standard-of-care DataJul 31, 2025 · Application 19177402Pending
- Biological Image Transformation Using Machine-learning ModelsJun 17, 2025 · US 12,332,970Granted
- Systems And Methods For Determining Tissue Microarray Sampling ProtocolsJun 17, 2025 · US 12,333,725Granted
- Machine-learning-enabled Predictive Biomarker Discovery And Patient Stratification Using Standard-of-care DataMay 13, 2025 · US 12,299,884Granted
- Systems And Methods For Artifact Detection And Removal From Image DataMay 13, 2025 · US 12,299,856Granted
- Cellular Time-series Imaging, Modeling, And Analysis SystemApr 15, 2025 · US 12,277,711Granted
- Discovery PlatformMar 25, 2025 · US 12,260,946Granted
- Discovery PlatformMar 25, 2025 · US 12,260,945Granted
- In Situ Sequencing Of Rna Transcripts With Non-uniform 5' EndsMar 20, 2025 · Application 18938504Pending
- Autonomous Cell Imaging And Modeling SystemJan 14, 2025 · US 12,198,344Granted
- System, Devices And/or Processes For Updating Call GraphsDec 31, 2024 · US 12,182,202Granted
- Predicting Cellular Pluripotency Using Contrast ImagesDec 12, 2024 · Application 18746658Pending
- In Situ Sequencing Of Rna Transcripts With Non-uniform 5 Prime EndsDec 10, 2024 · US 12,163,190Granted
- Liver Fat Quantification From Dexa DataDec 10, 2024 · US 12,165,323Granted
- Cellular Time-series Imaging, Modeling, And Analysis SystemNov 21, 2024 · Application 18666672Pending
- Predicting Cellular Responses To PerturbationsNov 21, 2024 · Application 18667968Pending
- Synthetic Barcoding Of Cell Line Background GeneticsSep 12, 2024 · Application 18277358Pending
- Autonomous Maintenance And Differentiation Of Induced Pluripotency CellsSep 5, 2024 · Application 18592877Pending
- Pooled Optical Screening And Transcriptional Measurements Of Cells Comprising Barcoded Genetic PerturbationsAug 1, 2024 · Application 18113481Pending
- Predicting Cellular Pluripotency Using Contrast ImagesJul 23, 2024 · US 12,045,982Granted
Related companies, and why
- NOVICI BIOTECH, LLCSimilar federal contract value in Biotech · null in contracts
- AERIE PHARMACEUTICALS INCSimilar federal contract value in Biotech · null in contracts
- Gate BioscienceSimilar federal contract value in Biotech · null in contracts
- Nurix TherapeuticsSimilar federal contract value in Biotech · null in contracts
- FIVE ELEVEN PHARMA, INC.Similar federal contract value in Biotech · null in contracts
- Z BIOTECH, LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .